30. September 2022 • Knowledge intensive service
The Leipzig Office for Economic Development has joined biosaxony, the industry association of the life science cluster in Saxony. The aims of membership are to better represent the interests of the City of Leipzig, to strengthen existing collaborations and partnerships, and to directly support businesses, clinics, research centers, and transfer institutions based in the city.
One of the shared objectives of biosaxony and the City of Leipzig is to initiate projects between industry and the research community in biotech, health technology and healthcare. Other aims include supporting innovative startups in these sectors, promoting sustainable technology transfer, and creating new, highly qualified jobs in the medium term.
biosaxony has already been awarded and carried out several projects in and for Leipzig with life science partners from industry and science. One of these is the recently opened Medical Forge accelerator program, which simplifies the final step for startups and SMEs trying to enter the German healthcare market, and attracts German and foreign companies to Saxony. The fact that the key industry event BIO-Europe 2022 will shortly be held in Leipzig (October 24–26) is also the result of Leipzig’s partnership with biosaxony.
Clemens Schülke, acting head of the Department of Economic Affairs, Employment and Digital Transformation, declared: “We’re determined to reinforce Leipzig as a biotech hub. We’ve already taken important steps. I see enormous future potential in Medical Forge attracting pioneering companies to Leipzig. By joining biosaxony, we’re consolidating our close cooperation over the past few years and laying the foundations for new projects.”
Dr. Oliver Uecke, the Chair of biosaxony, welcomed the new member as follows: “In recent years, Leipzig has become a driver for the development of the life science industry in Saxony. In particular, the constant, successful efforts by the City of Leipzig to create additional laboratory space for spin-offs and growth companies on the BioCity Campus have played a key role. We’re delighted that we can now step up our already fruitful cooperation.”
biosaxony has 136 members, 46 of which are from Leipzig. They include representatives of industry, R&D centers, local government, the biotech and health technology industries, hospitals and healthcare, and digital technology.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
digital-health
Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
services
Woman who looks at something through a microscope while another woman ist watching her
The European Commission has approved the Saxon ERDF/JTF program for the funding period 2021 to 2027.
